CNBC’s Jim Cramer on Friday pointed out the number of biopharma mergers and acquisitions that have closed or been announced over the
Tag: Cerevel Therapeutics Holdings Inc
Investors see a biotech comeback in 2024 as rates fall, deal-making picks up. Stocks to watch
Many biotech stocks struggled in 2023 despite a robust year for U.S. drug approvals. As these new therapies begin treating patients, some
AbbVie to acquire Cerevel Therapeutics for $8.7 billion
A sign stands outside a Abbvie facility in Cambridge, Massachusetts, May 20, 2021. Brian Snyder | Reuters AbbVie on Wednesday said it
Bank of America reveals its Q1 picks
BofA has added a number of biotechnology stocks — a sector that is hot on Wall Street right now – to its
No More Posts Available.
No more pages to load.